Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
These findings provide new perspectives and potential targets for immunotherapy and prognostic evaluation of ovarian cancer and offer new strategies and directions for clinical treatment and patient management. This study provides crucial information to further our comprehension of drug response mechanisms and tumor immunotherapy. It offers new strategies and methods for the treatment and prognostic improvement of ovarian cancer.
Authors
- Wei Fang (ORCID: https://orcid.org/0000-0003-1920-8832)
- Jingfang Wang (ORCID: https://orcid.org/0000-0002-1355-5481)
- Weihong Zhao (ORCID: https://orcid.org/0000-0002-9645-7499)
- Yuanyuan Wu (ORCID: https://orcid.org/0000-0001-6231-2315)
- Wenhao Wang (ORCID: https://orcid.org/0000-0002-0971-4232)
- Yangzhou Wang
- Xia Li (ORCID: https://orcid.org/0000-0001-6006-7205)
- Wenrui Zhu (ORCID: https://orcid.org/0009-0008-2402-1822)
- Wenhui Ma (ORCID: https://orcid.org/0000-0002-6454-8353)
Institutions
- Shanxi Medical University (CN)
- Changzhi Medical College (CN)
- Second Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3389/fphar.2025.1500251
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 4.18